Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

380 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

NCT05671835

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • The Kirklin Clinic of University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine (UCI) Health Orange, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

NCT06230822

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Peking University Third Hospital Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
  • The First People's Hospital of Kashi Prefecture, Xinjiang Kashgar, China
View Trial Details
Completed

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT06335303

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Critical Care, Pulmonary and Sleep Associates Lakewood, Colorado, United States
  • Clinical Research Specialists LLC - Kissimmee Kissimmee, Florida, United States
  • SEC Clinical Research Pensacola, Florida, United States
View all 163 locations
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

NCT07344558

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • VALDI Fresno, California, United States
  • Palmtree Clinical Research Palm Springs, California, United States
  • Innova Pharma Research Doral, Florida, United States
  • New Life Medical Research Hialeah, Florida, United States
View Trial Details

Related conditions